Extracorporeal treatment of erythrocytes in sickle cell anemia: hemoglobin carbamylation.
D000755:Anemia, Sickle Cell / Q000188:drug therapy* / Q000503:physiopathology; D000818:Animals; D000986:Antisickling Agents / Q000627:therapeutic use; D001164:Arteriovenous Fistula; D002219:Carbamates / Q000378:metabolism*; D003485:Cyanates / Q000627:therapeutic use; D004285:Dogs; D004913:Erythrocytes, Abnormal / Q000187:drug effects*; D006451:Hemoglobin, Sickle / Q000378:metabolism*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007958:Leukocyte Count; D006435:Renal Dialysis / Q000379:methods*
D000986:Antisickling Agents; D002219:Carbamates; D003485:Cyanates; D006451:Hemoglobin, Sickle